Web Results

en.wikipedia.org/wiki/Delavirdine

Delavirdine (DLV) (brand name Rescriptor) is a non-nucleoside reverse transcriptase inhibitor ... Jump up ^ D. L. Romero et al., WO 9109849 ; J. R. Palmer et al., U.S. Patent ... Jump up ^ Romero, D. L.; Morge, R. A.; Genin, M. J.; Biles, C.; Busso, M.; .... Non-nucleoside reverse transcriptase inhibitors · Pfizer · Pyridines ...

securities.stanford.edu/filings-documents/1044/PFE00_01/2015217_r01x_10CV03864.pdf

vs. PFIZER INC., et al,,. Defendants. Civil Action No. I: LO-cv-03864-AKH ... the proposed settlement of the case entitled Mary K. Jones i& Pfizer Inc., ci at, Civil ...

securities.stanford.edu/filings-documents/1044/PFE00_01/2010126_r01c_10CV03864.pdf

Dec 6, 2010 ... CLASS ACTION. Plaintiff. : : CONSOLIDATED CLASS ACTION vs. ... (“Pfizer” or the “Company”) securities between 1/19/06 and 1/23/09 (the ...

www.law360.com/cases/4d381a64b1439212bd00004f

Parties, docket activity and news coverage of federal case Jones et al v. Pfizer, Inc. et al, case number 1:10-cv-03864, from New York Southern Court.

cas-cdc-www02.cas-satj.gc.ca/fct-cf/html/t_pr_e.htm

T-402-16, PFIZER CANADA INC. ET AL v. APOTEX INC. ET AL (MTG/TC-English ) ... T-464-16, JOHN BILES v. AGC (JR-English) ... ET AL v. PHARMASCIENCE INC. (CMC/TC-English) Patent Infringement, 01, 14:00, 1h. T-1627-16, ELI LILLY  ...

casetext.com/case/medimmune-inc-v-genentech-inc-no-05-608-us-192007

Pfizer, Inc., 395 F. 3d 1324, 1333 (2005)). ... Quoted 9 times; The other case the dissent cites for the point, Calderon v. ..... respondent Genentech, Inc., were J. Scott Ballenger, Amanda P. Biles, Daniel M. Wall, Mark A. Flagel ... Marjorie E. Powell; for Qualcomm Inc. et al. by E. Joshua Rosenkranz and Alan H. Blankenheimer; ...

www.courtlistener.com/opinion/145767/medimmune-inc-v-genentech-inc

Jan 9, 2007 ... Genentech, Inc., 549 U.S. 118, 127 S. Ct. 764, 166 L. Ed. 2d 604, 2007 U.S. LEXIS 1003. ... GENENTECH, INC., et al. ... J. Scott Ballenger, Nathaniel A. Vitan, Amanda P. Biles, Jeffrey Manns, ... States Court of Appeals for the Federal Circuit in Gen-Probe Inc. v. ...... Pfizer, Inc., 395 F.3d 1324, 1333 (2005)).

www.azag.gov/sites/default/files/documents/files/2010AnnualReport.pdf

Sep 8, 2010 ... $33 million deceptive marketing settlement with Pfizer, Inc. • The highest award given by the National Association of Attorneys General.

eurjmedres.biomedcentral.com/articles/10.1186/2047-783X-16-4-159

Apr 28, 2011 ... ... was approved first in 2001; 2) Anidulafungin (VER-002, LY303366, Eraxis®, Pfizer, Inc., New York, NY, ..... The volume of distribution at steady state (Vss) was approximately 18-19 litres. ... into an inactive open-ring peptide, and is excreted in the bile [12]. ..... Hernandez S, Lopez-Ribot JL, Najvar LK, et al.

web-app.usc.edu/web/pharmacy/faculty/img/293-CV_SHEN_2017_Feb.pdf

2006-present - John A. Biles Professor in Pharmaceutical Sciences, School of Pharmacy,. University of ... Biophysics, Biochemical Pharmacology, Biochemistry, Biochimica et Biophysica Acta, ... Principle Scientist, Pfizer Inc. Xiaoying ..... Larionova NV, Malykh EV, Villemson AL, Krasota AJu, Duchene D, Ollivon M, Gernet M,.